{"id":"https://openalex.org/W4399324924","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.e14533","title":"Non-clinical evaluation of NT-112, an autologous T cell product engineered to express an HLA-C*08:02-restricted TCR targeting KRAS G12D and resistant to TGF-b inhibition.","display_name":"Non-clinical evaluation of NT-112, an autologous T cell product engineered to express an HLA-C*08:02-restricted TCR targeting KRAS G12D and resistant to TGF-b inhibition.","publication_year":2024,"publication_date":"2024-06-01","ids":{"openalex":"https://openalex.org/W4399324924","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.e14533"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2024.42.16_suppl.e14533","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.e14533","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.e14533","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048304251","display_name":"Jennifer Ma","orcid":"https://orcid.org/0000-0001-8133-2282","observed_orcids":["https://orcid.org/0000-0001-8133-2282"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer Ma","raw_affiliation_strings":["Neogene Therapeutics, Santa Monica, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neogene Therapeutics, Santa Monica, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044394979","display_name":"Vanessa Tubb","orcid":"https://orcid.org/0000-0002-5199-8494","observed_orcids":["https://orcid.org/0000-0002-5199-8494"]},"institutions":[{"id":"https://openalex.org/I4210088281","display_name":"Stedelijk Museum Amsterdam","ror":"https://ror.org/006a5r035","country_code":"NL","type":"archive","lineage":["https://openalex.org/I4210088281"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Vanessa Tubb","raw_affiliation_strings":["Neogene Therapeutics, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neogene Therapeutics, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4210088281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090140313","display_name":"Michelle Mojadidi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michelle Mojadidi","raw_affiliation_strings":["Neogene Therapeutics, Santa Monica, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neogene Therapeutics, Santa Monica, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085316837","display_name":"Kayla Meade","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kayla Meade","raw_affiliation_strings":["Neogene Therapeutics, Santa Monica, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neogene Therapeutics, Santa Monica, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107031150","display_name":"Xiangjun Kong","orcid":"https://orcid.org/0000-0001-6105-1205","observed_orcids":["https://orcid.org/0000-0001-6105-1205"]},"institutions":[{"id":"https://openalex.org/I4210088281","display_name":"Stedelijk Museum Amsterdam","ror":"https://ror.org/006a5r035","country_code":"NL","type":"archive","lineage":["https://openalex.org/I4210088281"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Xiangjun Kong","raw_affiliation_strings":["Neogene Therapeutics, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neogene Therapeutics, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4210088281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035625076","display_name":"Paula Kroon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088281","display_name":"Stedelijk Museum Amsterdam","ror":"https://ror.org/006a5r035","country_code":"NL","type":"archive","lineage":["https://openalex.org/I4210088281"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Paula Kroon","raw_affiliation_strings":["Neogene Therapeutics, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neogene Therapeutics, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4210088281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112161426","display_name":"Aastha Sareen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088281","display_name":"Stedelijk Museum Amsterdam","ror":"https://ror.org/006a5r035","country_code":"NL","type":"archive","lineage":["https://openalex.org/I4210088281"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Aastha Sareen","raw_affiliation_strings":["Neogene Therapeutics, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neogene Therapeutics, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4210088281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066290966","display_name":"Bas Stringer","orcid":"https://orcid.org/0000-0001-7792-9385","observed_orcids":["https://orcid.org/0000-0001-7792-9385"]},"institutions":[{"id":"https://openalex.org/I4210088281","display_name":"Stedelijk Museum Amsterdam","ror":"https://ror.org/006a5r035","country_code":"NL","type":"archive","lineage":["https://openalex.org/I4210088281"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Bas Stringer","raw_affiliation_strings":["Neogene Therapeutics, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neogene Therapeutics, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4210088281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073527632","display_name":"Oscar Krijgsman","orcid":"https://orcid.org/0000-0003-0825-3291","observed_orcids":["https://orcid.org/0000-0003-0825-3291"]},"institutions":[{"id":"https://openalex.org/I4210088281","display_name":"Stedelijk Museum Amsterdam","ror":"https://ror.org/006a5r035","country_code":"NL","type":"archive","lineage":["https://openalex.org/I4210088281"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Oscar Krijgsman","raw_affiliation_strings":["Neogene Therapeutics, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neogene Therapeutics, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4210088281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088693665","display_name":"Yvonne B. Claassen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088281","display_name":"Stedelijk Museum Amsterdam","ror":"https://ror.org/006a5r035","country_code":"NL","type":"archive","lineage":["https://openalex.org/I4210088281"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Yvonne Claasen","raw_affiliation_strings":["Neogene Therapeutics, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neogene Therapeutics, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4210088281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053620374","display_name":"Jules Gadiot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088281","display_name":"Stedelijk Museum Amsterdam","ror":"https://ror.org/006a5r035","country_code":"NL","type":"archive","lineage":["https://openalex.org/I4210088281"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jules Gadiot","raw_affiliation_strings":["Neogene Therapeutics, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neogene Therapeutics, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4210088281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109629861","display_name":"Karen Buchner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088281","display_name":"Stedelijk Museum Amsterdam","ror":"https://ror.org/006a5r035","country_code":"NL","type":"archive","lineage":["https://openalex.org/I4210088281"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Karen Buchner","raw_affiliation_strings":["Neogene Therapeutics, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neogene Therapeutics, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4210088281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008265011","display_name":"Sander Eshuis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088281","display_name":"Stedelijk Museum Amsterdam","ror":"https://ror.org/006a5r035","country_code":"NL","type":"archive","lineage":["https://openalex.org/I4210088281"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Sander Eshuis","raw_affiliation_strings":["Neogene Therapeutics, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neogene Therapeutics, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4210088281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001016649","display_name":"Ton N. Schumacher","orcid":"https://orcid.org/0000-0003-0517-8804","observed_orcids":["https://orcid.org/0000-0003-0517-8804"]},"institutions":[{"id":"https://openalex.org/I4210088281","display_name":"Stedelijk Museum Amsterdam","ror":"https://ror.org/006a5r035","country_code":"NL","type":"archive","lineage":["https://openalex.org/I4210088281"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Ton Schumacher","raw_affiliation_strings":["Neogene Therapeutics, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neogene Therapeutics, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4210088281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017860538","display_name":"Carsten Linneman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088281","display_name":"Stedelijk Museum Amsterdam","ror":"https://ror.org/006a5r035","country_code":"NL","type":"archive","lineage":["https://openalex.org/I4210088281"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Carsten Linneman","raw_affiliation_strings":["Neogene Therapeutics, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neogene Therapeutics, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4210088281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025446665","display_name":"Thomas Kuilman","orcid":"https://orcid.org/0000-0001-6724-6767","observed_orcids":["https://orcid.org/0000-0001-6724-6767"]},"institutions":[{"id":"https://openalex.org/I4210088281","display_name":"Stedelijk Museum Amsterdam","ror":"https://ror.org/006a5r035","country_code":"NL","type":"archive","lineage":["https://openalex.org/I4210088281"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Thomas Kuilman","raw_affiliation_strings":["Neogene Therapeutics, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neogene Therapeutics, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4210088281"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jeroen van Heijst","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeroen van Heijst","raw_affiliation_strings":["Neogene Therapeutics, Amsterdam, CA, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neogene Therapeutics, Amsterdam, CA, Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067213272","display_name":"Gavin M. Bendle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088281","display_name":"Stedelijk Museum Amsterdam","ror":"https://ror.org/006a5r035","country_code":"NL","type":"archive","lineage":["https://openalex.org/I4210088281"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Gavin Bendle","raw_affiliation_strings":["Neogene Therapeutics, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neogene Therapeutics, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4210088281"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036672491","display_name":"Arianne Perez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arianne Perez","raw_affiliation_strings":["Neogene Therapeutics, Santa Monica, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neogene Therapeutics, Santa Monica, CA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"16_suppl","first_page":"e14533","last_page":"e14533"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.8939999938011169,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.8939999938011169,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.06689999997615814,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.01600000075995922,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kras-g12d","display_name":"KRAS G12D","score":0.9470000267028809},{"id":"https://openalex.org/keywords/tgf-beta-inhibition","display_name":"TGF-beta inhibition","score":0.6499999761581421},{"id":"https://openalex.org/keywords/adoptive-t-cell-therapy","display_name":"adoptive T cell therapy","score":0.6330000162124634},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.7049999833106995},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/neoantigen-specific-t-cells","display_name":"neoantigen-specific T cells","score":0.6330000162124634},{"id":"https://openalex.org/keywords/crispr-cas9-genome-editing","display_name":"CRISPR/Cas9 genome editing","score":0.8019999861717224},{"id":"https://openalex.org/keywords/off-target-editing","display_name":"off-target editing","score":0.7269999980926514},{"id":"https://openalex.org/keywords/genotoxicity","display_name":"genotoxicity","score":0.6769999861717224},{"id":"https://openalex.org/keywords/cross-reactivity","display_name":"cross-reactivity","score":0.7559999823570251},{"id":"https://openalex.org/keywords/alloreactivity","display_name":"alloreactivity","score":0.796999990940094}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7893924713134766},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.7332062125205994},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5582221150398254},{"id":"https://openalex.org/C19317047","wikidata":"https://www.wikidata.org/wiki/Q412037","display_name":"T-cell receptor","level":4,"score":0.5312219858169556},{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.5022881031036377},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.36716192960739136},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3477153182029724},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.24492552876472473},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23118117451667786},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.21582713723182678},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.12565869092941284},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2024.42.16_suppl.e14533","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.e14533","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.e14533","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.5400000214576721,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1686926070","https://openalex.org/W4367603427","https://openalex.org/W2040128205","https://openalex.org/W2060075608","https://openalex.org/W2026444950","https://openalex.org/W2092033815","https://openalex.org/W4395677914","https://openalex.org/W2168929838","https://openalex.org/W2140205174","https://openalex.org/W2037024992"],"abstract_inverted_index":{"e14533":[0],"Background:":[1],"Adoptive":[2],"transfer":[3],"of":[4,101,164,188,202,214,223,248,262,268,329],"T-cell":[5,64,175,236,263,333],"receptor":[6,84],"(TCR)-engineered":[7],"T-cells":[8,89,106,273],"to":[9,81,91,117,210,276],"target":[10,232],"shared":[11],"cancer":[12,338],"neoantigens":[13],"is":[14,60,78],"a":[15,162,246,316,330],"promising":[16],"new":[17],"immunotherapy":[18],"approach":[19],"for":[20,322,335],"patients":[21],"harboring":[22],"mutations":[23,30,40],"in":[24,31,41,53,94,113,151,153,157,216,255,265,280,299,308],"oncogenes":[25],"such":[26],"as":[27,243],"KRAS.":[28],"Activating":[29],"KRAS":[32,45,51,74,172,228,251],"are":[33,107],"among":[34],"the":[35,48,73,95,137,171,224,266],"most":[36,49],"prevalent":[37],"oncogenic":[38],"driver":[39],"human":[42],"cancers,":[43],"with":[44,161],"G12D":[46,75,133,173,229],"being":[47],"frequent":[50],"mutation":[52],"colorectal":[54],"carcinoma":[55],"and":[56,104,115,122,128,156,183,193,230,238,257,260,292,319,324],"pancreatic":[57],"cancer.":[58],"NT-112":[59,77,146,189,225,272,300,323],"an":[61,67,130],"autologous":[62],"engineered":[63,80],"product":[65,147,190,334],"expressing":[66,170],"HLA-C*08:02-restricted":[68,131],"TCR":[69,123,135,138,226],"that":[70],"specifically":[71],"targets":[72],"mutation.":[76,174],"additionally":[79],"lack":[82,247,261],"TGF-\u03b2":[83],"II":[85],"(TGFBR2)":[86],"expression,":[87],"rendering":[88],"insensitive":[90],"TGF-b-mediated":[92],"inhibition":[93],"tumor":[96,278],"microenvironment.":[97],"Methods:":[98],"For":[99,186],"manufacturing":[100],"NT-112,":[102],"CD4":[103],"CD8":[105],"enriched":[108],"from":[109],"leukapheresis":[110],"material,":[111],"activated":[112],"vitro":[114,158],"gene-edited":[116],"knock-out":[118],"both":[119,152],"endogenous":[120],"TGFBR2":[121],"\u03b2":[124],"constant":[125,140],"1/2":[126],"(TRBC1/2)":[127],"knock-in":[129],"KRS":[132],"neoantigen-specific":[134],"at":[136],"\u03b1":[139],"(TRAC)":[141],"locus":[142],"using":[143],"CRISPR-Cas9":[144],"technology.":[145],"functionality":[148,239],"was":[149,177,208,234,240],"evaluated":[150],"vivo":[154],"models":[155],"co-culture":[159],"experiments":[160],"panel":[163],"cell":[165],"lines":[166],"including":[167],"those":[168],"endogenously":[169],"reactivity":[176,222,249],"assessed":[178],"by":[179,206,245],"measuring":[180],"cytotoxicity,":[181],"proliferation,":[182],"cytokine":[184],"production.":[185],"determination":[187],"safety,":[191],"cross-reactivity":[192,254],"allo-reactivity":[194],"assessments":[195],"were":[196,274,297],"carried":[197],"out.":[198],"A":[199],"comprehensive":[200],"analysis":[201],"potential":[203,212],"off-target":[204,293],"editing":[205],"CRISPR/Cas9":[207],"performed":[209],"assess":[211],"risk":[213],"genotoxicity":[215],"clinical":[217,327],"grade":[218],"NT-112.":[219],"Results:":[220],"High":[221],"against":[227,250],"HLA-C*08:02-expressing":[231],"cells":[233],"observed.":[235],"activation":[237,264],"highly":[241],"specific,":[242],"demonstrated":[244],"WT,":[252],"minimal":[253],"Alanine":[256],"Glycine":[258],"scans,":[259],"absence":[267],"HLA-C*08:02.":[269],"In":[270],"vivo,":[271],"able":[275],"induce":[277],"clearance":[279],"two":[281],"independent":[282],"models.":[283],"Low":[284],"frequency":[285],"chromosomal":[286],"translocation":[287],"events":[288],"(<0.1%)":[289],"between":[290],"on-target":[291],"Cas9":[294],"cleavage":[295],"sites":[296],"detectable":[298],"T-cells.":[301],"However":[302],"importantly,":[303],"these":[304],"did":[305],"not":[306],"result":[307],"autonomous":[309],"cytokine-independent":[310],"growth.":[311],"Conclusions:":[312],"Non-clinical":[313],"studies":[314],"revealed":[315],"favorable":[317],"safety":[318],"efficacy":[320],"profile":[321],"supported":[325],"further":[326],"development":[328],"TGF-\u03b2-resistant":[331],"TCR-edited":[332],"mutant":[336],"KRAS-targeted":[337],"immunotherapy.":[339]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}